Cargando…
γ‐Secretase modulators show selectivity for γ‐secretase–mediated amyloid precursor protein intramembrane processing
The aggregation of β‐amyloid peptide 42 results in the formation of toxic oligomers and plaques, which plays a pivotal role in Alzheimer's disease pathogenesis. Aβ42 is one of several Aβ peptides, all of Aβ30 to Aβ43 that are produced as a result of γ‐secretase–mediated regulated intramembrane...
Autores principales: | Weber, Tobias A., Lundkvist, Johan, Wanngren, Johanna, Kvartsberg, Hlin, Jin, ShaoBo, Larssen, Pia, Wu, Dan, Oliveira, Daniel V., Minta, Karolina, Brinkmalm, Gunnar, Zetterberg, Henrik, Blennow, Kaj, Nordvall, Gunnar, Winblad, Bengt, Portelius, Erik, Karlström, Helena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8817114/ https://www.ncbi.nlm.nih.gov/pubmed/34931449 http://dx.doi.org/10.1111/jcmm.17146 |
Ejemplares similares
-
Mechanism of Intramembrane Cleavage of Alcadeins by γ-Secretase
por: Piao, Yi, et al.
Publicado: (2013) -
APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment
por: Sjödin, Simon, et al.
Publicado: (2015) -
Substrate–Enzyme Interactions in Intramembrane Proteolysis: γ-Secretase as the Prototype
por: Liu, Xinyue, et al.
Publicado: (2020) -
A novel Aβ isoform pattern in CSF reflects γ-secretase inhibition in Alzheimer disease
por: Portelius, Erik, et al.
Publicado: (2010) -
Gamma-secretase modulators: a promising route for the treatment of Alzheimer's disease
por: Nordvall, Gunnar, et al.
Publicado: (2023)